Role code
| Indications
| Reaction
| # Reports
|
SS
| DEPRESSION
| APHASIA
| 3
|
SS
| DEPRESSION
| CEREBRAL HAEMATOMA
| 3
|
SS
| DEPRESSION
| FALL
| 3
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| AGRANULOCYTOSIS
| 7
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| CHOLESTASIS
| 9
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| CYTOLYTIC HEPATITIS
| 9
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS
| 16
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| NEUTROPENIA
| 9
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| PANCYTOPENIA
| 7
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| PROTEINURIA
| 9
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| TOXIC EPIDERMAL NECROLYSIS
| 9
|
SS
| PRODUCT USED FOR UNKNOWN INDICATION
| VENTRICULAR FIBRILLATION
| 7
|
C
| ABNORMAL BEHAVIOUR
| AFFECTIVE DISORDER
| 1
|
C
| ABNORMAL BEHAVIOUR
| ANTICONVULSANT DRUG LEVEL INCREASED
| 1
|
C
| ABNORMAL BEHAVIOUR
| COAGULATION FACTOR DECREASED
| 1
|
C
| ABNORMAL BEHAVIOUR
| CONVULSION
| 1
|
C
| ABNORMAL BEHAVIOUR
| DRUG EFFECT DECREASED
| 1
|
C
| ABNORMAL BEHAVIOUR
| FALL
| 1
|
C
| ABNORMAL BEHAVIOUR
| LACERATION
| 1
|
C
| ABNORMAL BEHAVIOUR
| PLATELET AGGREGATION DECREASED
| 1
|
C
| ABNORMAL BEHAVIOUR
| RENAL DISORDER
| 1
|
C
| ABNORMAL BEHAVIOUR
| SUICIDAL BEHAVIOUR
| 1
|
C
| ABNORMAL BEHAVIOUR
| VON WILLEBRAND'S DISEASE
| 1
|
C
| ABNORMAL BEHAVIOUR
| WOUND HAEMORRHAGE
| 1
|
C
| COMPUTERISED TOMOGRAM
| HYPOTHERMIA
| 2
|
C
| COMPUTERISED TOMOGRAM
| PANCYTOPENIA
| 2
|
C
| DEHYDRATION
| HYPOTHERMIA
| 2
|
C
| DEHYDRATION
| PANCYTOPENIA
| 2
|
C
| DEMENTIA
| HYPOTHERMIA
| 4
|
C
| DEMENTIA
| PANCYTOPENIA
| 4
|
C
| EPILEPSY
| AFFECTIVE DISORDER
| 4
|
C
| EPILEPSY
| ANTICONVULSANT DRUG LEVEL INCREASED
| 4
|
C
| EPILEPSY
| COAGULATION FACTOR DECREASED
| 4
|
C
| EPILEPSY
| CONVULSION
| 4
|
C
| EPILEPSY
| DRUG EFFECT DECREASED
| 4
|
C
| EPILEPSY
| FALL
| 4
|
C
| EPILEPSY
| LACERATION
| 4
|
C
| EPILEPSY
| PLATELET AGGREGATION DECREASED
| 4
|
C
| EPILEPSY
| RENAL DISORDER
| 4
|
C
| EPILEPSY
| SUICIDAL BEHAVIOUR
| 4
|
C
| EPILEPSY
| VON WILLEBRAND'S DISEASE
| 4
|
C
| EPILEPSY
| WOUND HAEMORRHAGE
| 4
|
C
| PARKINSON'S DISEASE
| AFFECTIVE DISORDER
| 1
|
C
| PARKINSON'S DISEASE
| ANTICONVULSANT DRUG LEVEL INCREASED
| 1
|
C
| PARKINSON'S DISEASE
| COAGULATION FACTOR DECREASED
| 1
|
C
| PARKINSON'S DISEASE
| CONVULSION
| 1
|
C
| PARKINSON'S DISEASE
| DRUG EFFECT DECREASED
| 1
|
C
| PARKINSON'S DISEASE
| FALL
| 1
|
C
| PARKINSON'S DISEASE
| FEELING DRUNK
| 3
|
C
| PARKINSON'S DISEASE
| LACERATION
| 1
|
C
| PARKINSON'S DISEASE
| OROMANDIBULAR DYSTONIA
| 3
|
C
| PARKINSON'S DISEASE
| PLATELET AGGREGATION DECREASED
| 1
|
C
| PARKINSON'S DISEASE
| RENAL DISORDER
| 1
|
C
| PARKINSON'S DISEASE
| SOMNOLENCE
| 3
|
C
| PARKINSON'S DISEASE
| SUICIDAL BEHAVIOUR
| 1
|
C
| PARKINSON'S DISEASE
| VON WILLEBRAND'S DISEASE
| 1
|
C
| PARKINSON'S DISEASE
| WOUND HAEMORRHAGE
| 1
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| AFFECTIVE DISORDER
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| ANTICONVULSANT DRUG LEVEL INCREASED
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| COAGULATION FACTOR DECREASED
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| CONVULSION
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| DECREASED APPETITE
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| DRUG EFFECT DECREASED
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| FALL
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| HYPOTHERMIA
| 1
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| LACERATION
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| MENTAL DISORDER
| 10
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| PANCYTOPENIA
| 1
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| PLATELET AGGREGATION DECREASED
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| RENAL DISORDER
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| SUICIDAL BEHAVIOUR
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| TOXICITY TO VARIOUS AGENTS
| 10
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| VON WILLEBRAND'S DISEASE
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| WEIGHT DECREASED
| 4
|
C
| PRODUCT USED FOR UNKNOWN INDICATION
| WOUND HAEMORRHAGE
| 4
|
C
| PSYCHOTIC DISORDER
| DECREASED APPETITE
| 2
|
C
| PSYCHOTIC DISORDER
| HYPOTHERMIA
| 2
|
C
| PSYCHOTIC DISORDER
| PANCYTOPENIA
| 2
|
C
| PSYCHOTIC DISORDER
| WEIGHT DECREASED
| 2
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| AGRANULOCYTOSIS
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| BONE MARROW FAILURE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| CONFUSIONAL STATE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| CONVULSION
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| COSTOVERTEBRAL ANGLE TENDERNESS
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| COUGH
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| CREATININE RENAL CLEARANCE DECREASED
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| DELIRIUM
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| DYSURIA
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| ERYTHEMA
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| ESCHERICHIA TEST POSITIVE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| HAEMODYNAMIC INSTABILITY
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| HALLUCINATION
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| HEART RATE INCREASED
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| HYPOTENSION
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| INCOHERENT
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| LEUKOPENIA
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| OBSTRUCTIVE AIRWAYS DISORDER
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| PYREXIA
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| RESPIRATORY TRACT CONGESTION
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| SEPSIS
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| SKIN LESION
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| SOMNOLENCE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| STAPHYLOCOCCUS TEST POSITIVE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| STREPTOCOCCUS TEST POSITIVE
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| TACHYCARDIA
| 1
|
C
| SCHIZOPHRENIA, PARANOID TYPE
| URINE ANALYSIS ABNORMAL
| 1
|
C
| THROMBOSIS PROPHYLAXIS
| DEEP VEIN THROMBOSIS
| 1
|
C
| URINARY TRACT INFECTION
| HYPOTHERMIA
| 2
|
C
| URINARY TRACT INFECTION
| PANCYTOPENIA
| 2
|